Disease caused by gastro esophageal reflux: New details of an old disease
Enfermedad por reflujo gastroesofágico. Detalles nuevos de una enfermedad vieja
##plugins.themes.bootstrap3.article.sidebar##
PDF (Español (España))
FLIP
HTML (Español (España))
##plugins.themes.bootstrap3.article.main##
Disease caused by gastro esophageal reflux is a pathology of great prevalence in the world. Its treatment is very expensive and requires a deep knowledge of physiopathological aspects to understand the clinic problems and make an appropriate management. Among the main
aspects of physiopathology, the spontaneous relaxations of lower esophageal sphincter are an important morbidity cause like other aspects included in this review. Within the clinical aspect, it is fundamental the erosive and non-erosive classification, in addition to the characterization
between atypical and typical symptoms in order to implement a treatment according to patient's needs.
Downloads
##plugins.themes.bootstrap3.article.details##
George, Karamanolis. 2007. Developments in pathogenesis and diagnosis of gastroesophageal reflux disease. Current Opinion in Gastroenterology 23:428-433.
Joel E., Richter. 2007. The Many Manifestations of Gastroesophageal Reflux Disease: Presentation, Evaluation, and Treatment. Gastroenterol Clin N Am 36:577-599.
American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease.Gastroenterology. 2008;135:1383-1391.
John E. Pandolfino. 2008. The Pathophysiologic basis for Epidemiologic Trends in Gastroesophageal Reflux. Disease gastro the clinics.
Mittal, RK. 1987. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology.
Souza, RC. 2009. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus 22(3):256-263.
Peter, J. Kahrilas. Gastroesophageal Reflux Disease. N Engl J Med 2008;359:1700-1707.
Non-acid reflux. 2009. Detection by multichannel intraluminal impedance and Ph, clinical significance and management. American journal of Gastroenterology, 104.
Jeanetta,Walters. 2008. Extraesophageal GERD. Gastroenterol Clin N Am 37:845-858.
Impact of PPIs on patient focused symptomatology in GERD, ABR Thomson. Therapeutics and Clinical Risk Management 4(6):1185-1200.
Ferrús, JA. 2009. Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study Eur J Gastroenterol Hepatol. May 23.
Garrean, C. 2009. Eosinophilic esophagitis: pathophysiology and optimal management. Curr Gastroenterol Rep. 11(3):175-181.
Sang Kuon, Yonsei. 2009. Laparoscopic Nissen Fundoplication in Korean Patients with Gastroesophageal. Reflux Disease, Med J 50(1):89-94.
Jones, R. 2008. The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor. Int J Clin Pract 62(12):1844-1850.
Savarino, E., Bazzica, M. 2009. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med Mar 1;179(5):408-413.
Eskiizmir, G., Kezirian E. 2009. Is there a vicious cycle between obstructive sleep apnea and laryngopharyngeal reflux disease? Med Hypotheses. Jun 1.
Wise, SK., Wise, JC., DelGaudio JM. 2006. Gastroesophageal reflux and laryngopharyngeal reflux in patients with sleep-disordered breathing. Otolaryngol Head Neck Surg 135(2):253-257.
AJ, Ngu., MC, Breslin AB. 2000. Obstructive sleep apnea and gastroesophageal reflux Ing. Am J Med Mar 6;108 Suppl 4a:120S-125S.
Bhardwaj, A, Hollenbeak, CS, Pooran N, Mathew A. 2009. A Meta-Analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett’s esophagus in patients with gastroesophageal reflux. Disease Am J Gastroenterol 104(6):1533-1539 .
Lin OS, Schembre, DB, Mergener, K, Spaulding W, Lomah N. 2007. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett’s esophagus in patients with chronic gastroesophageal reflux. Gastrointest Endosc 65(4):577-583.
Ramirez, FC, Akins, R, Shaukat, M. 2008. Screening of Barrett’s esophagus with stringcapsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard. Gastrointest Endosc 68(1):25-31.
Beaumont, H, Boeckxstaens, GE. 2009. Does the Presence of a Hiatal Hernia Affect the Efficacy of the Reflux Inhibitor Baclofen During Add-On Therapy? Am J Gastroenterol Jun 2.
Lehmann, A. 2008. Novel treatments of GERD: focus on the lower esophageal sphincter. Eur Rev Med Pharmacol Sci. 12 Suppl 1:103-110.
Boeckxstaens, GE. 2008. Reflux inhibitors: a new approach for GERD? Curr Opin Pharmacol. 8(6):685-689.
Vakil, N. 2008. New pharmacological agents for the treatment of gastroesophageal reflux disease. Rev Gastroenterol Disord. Spring; 8(2):117-122.
Tack, J. 2005. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease. Curr Opin Gastroenterol 21(4):454-460.
Ciccaglione, AF, Marzio, L. 2003. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal. Reflux disease Gut 52(4):464-470.
Vela, MF, Tutuian, R, Katz, PO, Castell, DO. 2003. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH Aliment. Pharmacol Ther 17(2):243-251.
Sidhu, AS, Triadafilopoulos G. 2008. Neuroregulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease. World J Gastroenterol 21;14(7): 985-990.
Wahab, A, Heinemann U, Albus K. 2009. Effects of gamma-aminobutyric acid (GABA) agonists and a GABA uptake inhibitor on pharmacoresistant seizure like events in organotypic hippocampal slice cultures. Epilepsy Res. Jun 15.
Gasiorowska, A, Navarro-Rodriguez, T, Wendel, C, Krupinski, E, Perry, ZH, Koenig, K, Moty, B, Powers, J, Fass, R. 2009. Comparison of the Degree of Duodenogastroesophageal Reflux and Acid Reflux Between Patients Who Failed to Respond and Those Who Were Successfully Treated With a Proton Pump Inhibitor Once Daily. Am J Gastroenterol. Jun 2.
Tack, J, Koek, G, Demedts, I, Sifrim, D, Janssens, J. 2004. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 99(6):989-990.
Dekel, R, Martinez-Hawthorne, SD, Guillen, RJ, Fass, R. 2004. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol 38(1):24-29.
Fennerty, MB, Johnson, DA. 2006. Heartburn severity does not predict disease severity in patients with erosive esophagitis. Med Gen Med 8(2):6.
Castell, DO, Kahrilas, PJ, Richter, JE. 2002. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97(3):575-583.
Long, JD, Orlando RC. 2008. Nonerosive reflux disease: a pathophysiologic perspective. Curr Gastroenterol Rep 10(3):200-207.
T. Omari, C. Barnett, A. Snel. Mechanism of gastroesophageal reflux in premature infants with chronic lung disease Journal of Pediatric Surgery 34(12):1795-1798.
Lundell, L, Miettinen, P, Myrvold, HE, Hatlebakk, JG, Wallin L. 2009. Comparison of outcomes 12 years after anti-reflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clin Gastroenterol Hepatol.
Lundell, L, Miettinen, P, Myrvold, HE, Hatlebakk, JG. 2007. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 94(2):198-203.
Lundell, L, Attwood, S, Ell, C, Fiocca, R, Galmiche, JP. 2008. Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastrooesophageal reflux disease: a 3-year interim analysis of the LOTUS trial Gut. 57(9):1207-1213. Epub 2008 May 9.
Mehta, S, Bennett, J, Mahon, D, Rhodes, M. 2006. Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up. J Gastrointest Surgl 10(9):1312-1316.
Dimitrijeviæ, M, Beljin, V, Petroviæ, V, Dukiæ V. 2009. Gastroesophageal reflux disease correlation with posterior laryngitis, Vojnosanit Pregl 66(5):383-387.
Vaezi, MF. 2008. Laryngeal manifestations of gastroesophageal reflux disease. Curr Gastroenterol Rep 10(3):271-277.
Farrokhi, F, Vaezi, MF. 2007. Laryngeal disorders in patients with gastroesophageal reflux disease, Minerva Gastroenterol Dietol 53(2):181-187.
Modlin, IM, Hunt, RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat. 2009. Diagnosis and Management of Non-Erosive Reflux Disease - The Vevey NERD Consensus Group. Digestion 80(2):74-88.
Wang, L, Liu, JX, Qin, YX, Wang, HM, Liu, HY , Zhonghua, Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009. Research on the relationship between obstructive sleep apnea hypopnea syndrome and gastroesophageal reflux 44(1):26-30.
Molle, LD, Goldani, HA, Fagondes, SC, Vieira, VG, Barros, SG, Silva, PS, Silveira, TR. 2009. Nocturnal reflux in children and adolescents with persistent asthma and gastroesophageal reflux J Asthma 46(4):347-350.
Babak Mokhlesi, MD, Aaron, L. Morris. 2001. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD, CHEST 119(4):1043-1048.
Ayazi, S, Hagen, JA, Chan, LS, Demeester, SR. 2009. Obesity and Gastroesophageal Reflux: Quantifying the Association between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a large series of patients with reflux symptoms. J Gastrointest Surg May 28.
Wu, JC, Mui, LM, Cheung, CM, Chan, Y, Sung, JJ. 2007. Obesity is associated with increased transient lower esophageal sphincter
relaxation. Gastroenterology 132(3):883-889.
Herbella, FA, Sweet, MP, Tedesco, P. 2007. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg 11(3):286-290.
Ferrús, JA, Zapardiel, J, Sobreviela, E. Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study Eur. J Gastroenterol Hepatol May 23.
Bretagne, JF, Richard-Molard, B. 2006.Gastroesophageal reflux in the French general population: national survey of 8000 adults Presse Med 35(1 Pt 1):23-31.
Armstrong, D, Marshall, JK, Chiba, N, Enns, R. 2005. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol 19(1):15-35.
Louis, E, Tack, J, Vandenhoven, G. 2009. Evaluation of the GERD impact scale, an international, validated patient questionnaire, in daily practice. Results of the ALEGRIA study. Acta Gastroenterol Belg 72(1):3-8.
Karoui, S, Serghini, M, Zouiten, L. 2008. How can we optimize the performances of 24-hour esophageal pH-monitoring for the diagnosis of gastroesophageal reflux disease? Tunis Med 86(10):861-864.
Karoui, S, Zouiten, L, Matri, S, Jomni, MT. 2007. Nocturnal gastroesophageal reflux disease in asthmatics patients: a pHmetric study about 81 cases Tunis Med. 85(12):1030-1034.
Biccas, BN, Lemme, EM, Abrahão, LJ Jr. 2009. Higher prevalence of obesity in erosive gastroesophageal reflux disease Arq. Gastroenterol 46(1):15-19.
Harding, SM. 2009. Sleep-Related Gastroesophageal Reflux: Evidence is Mounting? Clin Gastroenterol Hepatol.
Roland, MM, Baran, AS, Richert, AC. 2008. Sleep-related laryngospasm caused by gastroesophageal reflux Sleep Med 9(4):451-453. Epub 2007 Sep 17.
Fass, R. 2009. The relationship between gastroesophageal reflux disease and sleep. Curr Gastroenterol Rep 11(3):202-208.
Ford, CN. 2005. Evaluation and management of laryngopharyngeal reflux. JAMA 294(12):1534-1540.
Cutler, A, Robinson, M, Murthy, A. 2009. Rabeprazole 20 mg for erosive esophagitisassociated symptoms in a large, communitybased. Study: additional results. Dig Dis Sci Jun 26.
Ding, ZL, Xu XH, Wang, ZF, Zhonghua Yi Xue Za Zhi. 2009. Multi-channel electrogastrography and autonomic nervous system function in patients with non-erosive reflux disease and reflux esophagitis 89(4):263-265.
Lazarchik, DA, Frazier, KB. 2009. Dental erosion and acid reflux disease: an overview Gen Dent 57(2):151-156; quiz 157-158.
Vashani, K, Murugesh, M, Hattiangadi G. 2009. Effectiveness of voice therapy in refluxrelated voice disorders. Dis Esophagus.
Wang, C, Hunt, RH. 2008. Precise role of acid in non-erosive reflux disease. Digestion 2008;78(Suppl 1:31-41). Epub.
Remes-Troche JM, Gómez-Escudero, O. 2004. Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive. Rev Gastroenterol Mex 69(1):30-36.
